A dual proteomics analysis of paired cerebrospinal fluid and plasma from patients with neurodegenerative diseases

INTRODUCTIONUnderstanding concordance across biofluids and platforms is critical for understanding neurodegenerative biomarkers results and translating them into clinical use; yet systematic comparisons remain limited. To address this gap, we performed large-scale proteomic profiling of patient-pair